(Q34568898)

English

Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

phase I clinical trial

0 references

phase II clinical trial

0 references

0 references

author name string

Joseph Rosenthal

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jeffrey Wong

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Anthony Stein

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dajun Qian

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Debbie Hitt

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hossameldin Naeem

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Andrew Dagis

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sandra H Thomas

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Stephen Forman

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

28 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

117

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

309-315

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

7 July 2018

Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

7 July 2018

Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

7 July 2018

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

7 July 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

7 July 2018

HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

7 July 2018

Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

7 July 2018

Lung damage following bone marrow transplantation after hyperfractionated total body irradiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

7 July 2018

Interstitial pneumonitis after allogeneic bone marrow transplantation following total body irradiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

7 July 2018

Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

7 July 2018

Image-guided total marrow and total lymphatic irradiation using helical tomotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first compl

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Solid cancers after bone marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037752

27 October 2018

Secondary malignancies after bone marrow transplantation in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moe

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: Treatment technique and related complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benchmarking beam alignment for a clinical helical tomotherapy device

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/20876852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2010-06-288357

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34568898&oldid=1749483865"